{"id":"W2636042323","doi":"10.1016/j.ejca.2017.05.031","title":"Health-related quality of life results from the phase III CheckMate 067 study","year":2017,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":95,"is_retracted":false,"has_abstract":true,"ca_institutions":"Alberta Cancer Foundation","funders":"Genentech; Astellas Pharma; Merck Sharp and Dohme; Eisai; National Cancer Institute; Dendreon Pharmaceuticals; Incyte; Les Laboratories Pierre Fabre; Regeneron Pharmaceuticals; LEO Pharma; Prometheus; Helsinn; Roche; EMD Serono; Novartis; GlaxoSmithKline; Merck; Celgene; Bristol-Myers Squibb; AstraZeneca; Amgen; Pfizer","keywords":"Phase (matter); Medicine; Chemistry","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004613908,0.0007783693,0.001136051,0.0004558913,0.0003064113,0.0009827357,0.0006216964,0.0007086975,0.00206533],"category_scores_gemma":[0.002859925,0.0001977963,0.001980256,0.0006521574,0.0003388111,0.0003832924,0.0005200513,0.001091402,0.0004994341],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004838571,"about_ca_system_score_gemma":0.0004174103,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005847338,"about_ca_topic_score_gemma":0.001084139,"domain_scores_codex":[0.9986922,0.0007585785,0.00009979741,0.0001371486,0.0002343771,0.00007794729],"domain_scores_gemma":[0.9963624,0.001015267,0.00149145,0.0002356349,0.000346611,0.0005486382],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.4164011,0.006436458,0.4667861,0.002343803,0.01753354,0.0002169731,0.0002746266,0.004092838,0.007548172,0.0001998312,0.01284517,0.06532148],"study_design_scores_gemma":[0.06792286,0.04863559,0.8659726,0.0002093289,0.007092345,0.0004551078,0.0000888905,0.001841562,0.002526832,0.0001313084,0.005053273,0.00007024866],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9832374,0.005012055,0.0002965424,0.0001980036,0.0000496998,0.0004596654,0.008804043,0.00003004779,0.001912566],"genre_scores_gemma":[0.9733391,0.001437566,0.000543747,0.0004784068,0.00009209413,0.0007280137,0.0225694,0.00002457993,0.0007870395],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004613908,"threshold_uncertainty_score":0.02440095,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09786343728687633,"score_gpt":0.4043122046986372,"score_spread":0.3064487674117609,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}